Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-15-004853)

Filing Details

Accession Number:: 0001181431-15-004853
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-18 20:02:51
Reporting Period:: 2015-03-16

Filing Date:: 2015-03-18
Accepted Time:: 2015-03-18 20:02:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1396814	Pacira Pharmaceuticals Inc.	PCRX	Pharmaceutical Preparations (2834)	510619477

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1545439	Bullaro Lauren Riker	C/O Pacira Pharmaceuticals, Inc. 5 Sylvan Way, Suite 300 Parsippany NJ 07054	Executive Director, Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-03-16	5,000	$10.34	7,230	No	4	M	Direct
Common Stock	Disposition	2015-03-16	5,000	$95.34	2,230	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2015-03-16	5,000	$0.00	5,000	$10.34

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,000		2021-05-10	No	4	M	Direct

Footnotes

Includes 230 shares of common stock acquired under the issuer's employee stock purchase plan in December 2014.
The option vested and became exercisable as to 25% of the option shares on May 2, 2012 and vests as to the remaining shares in successive equal monthly installments for the subsequent 36 months.